Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avella announced it has been selected by Otsuka to distribute Jynarque, the FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
Avectas has entered into a collaborative agreement with The Simon Laboratory at UC Davis, California, USA (UCD) to engage in the characterization of cells engineered with Avectas' proprietary, non-viral SOLUPORE™ cell engineering platform.
read more
Thursday, February 01, 2018
Nitto Denko Avecia announced the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities.
read more
Avara has provided an update on Hurricane Maria's impact on the company's people and manufacturing facilities at our Arecibo, Puerto Rico site.
read more
Monday, September 19, 2016
Avara Pharmaceutical Services, Inc. recently celebrated their first year since the acquisition of their Arecibo, Puerto Rico, site from Merck. Since that time, Avara, headquartered in Norwalk, CT, (USA), now has four manufacturing facilities with ...
read more
Monday, February 03, 2020
During Q4 2019, Avara’s Liscate facility hosted the FDA as part of a Pre-Approval Inspection for a new Client’s product to be manufactured in the Small Volume Parenterals department.
read more
Avara Pharmaceutical announced the acquisition of the GlaxoSmithKline consumer healthcare manufacturing facility in Aiken, South Carolina is complete.
read more
Friday, September 07, 2018
Avara Pharmaceutical Services has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada.
read more
Avara has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a global pharmaceutical company, as part of a continuing expansion of its global footprint.
read more
Avara Pharmaceutical Services has signed an agreement with Pfizer to acquire the Liscate, Italy sterile manufacturing facility.
read more
Avara has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility.
read more
Friday, September 22, 2017
Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK consumer healthcare manufacturing facility in Aiken, South Carolina.
read more
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced a multi-year investment in its global hydration capabilities. The ...
read more
Avantor, Inc. has entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry.
read more
Wednesday, April 28, 2021
Avantor Inc. announces that it will increase global capacity for high-quality single-use technologies used in the production of biologics and vaccines.
read more